HomeCompareMTPR vs MRK

MTPR vs MRK: Dividend Comparison 2026

MTPR yields 1000000.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MTPR wins by $188409716392645591040.00M in total portfolio value
10 years
MTPR
MTPR
● Live price
1000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$188409716392645591040.00M
Annual income
$156,820,396,180,463,870,000,000,000.00
Full MTPR calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MTPR vs MRK

📍 MTPR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMTPRMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MTPR + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MTPR pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MTPR
Annual income on $10K today (after 15% tax)
$85,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$133,297,336,753,394,290,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MTPR beats the other by $133,297,336,753,394,290,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MTPR + MRK for your $10,000?

MTPR: 50%MRK: 50%
100% MRK50/50100% MTPR
Portfolio after 10yr
$94204858196322795520.00M
Annual income
$78,410,198,090,231,930,000,000,000.00/yr
Blended yield
83.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MTPR
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MTPR buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMTPRMRK
Forward yield1000000.00%2.81%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$188409716392645591040.00M$57.7K
Annual income after 10y$156,820,396,180,463,870,000,000,000.00$10,113.78
Total dividends collected$186170298512243982336.00M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MTPR vs MRK ($10,000, DRIP)

YearMTPR PortfolioMTPR Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$50,010,700$50,000,000.00$11,213$373.04+$50.00MMTPR
2$116,900,941,356$116,847,429,906.54$12,667$512.06+$116900.93MMTPR
3$127,757,345,946,658$127,632,261,939,407.38$14,439$708.14+$127757345.93MMTPR
4$65,316,731,768,579,704$65,180,031,408,416,776.00$16,640$988.16+$65316731768.56MMTPR
5$15,641,708,257,005,480,000$15,571,819,354,013,100,000.00$19,432$1,394.07+$15641708257005.46MMTPR
6$1,759,286,910,766,321,500,000$1,742,550,282,931,325,600,000.00$23,057$1,992.90+$1759286910766321.50MMTPR
7$93,467,370,779,778,750,000,000$91,584,933,785,258,800,000,000.00$27,889$2,894.79+$93467370779778752.00MMTPR
8$2,373,712,470,630,401,000,000,000$2,273,702,383,896,037,800,000,000.00$34,518$4,286.29+$2373712470630401024.00MMTPR
9$29,522,729,170,263,285,000,000,000$26,982,856,826,688,750,000,000,000.00$43,912$6,494.35+$29522729170263285760.00MMTPR
10$188,409,716,392,645,600,000,000,000$156,820,396,180,463,870,000,000,000.00$57,714$10,113.78+$188409716392645591040.00MMTPR

MTPR vs MRK: Complete Analysis 2026

MTPRStock

MetaPower International, Inc. operates as a management-consulting and technology company in North America. The company offers Noble Production, a suite of automated processes and attendant services that provide heavy industrial facilities with the tools necessary to guide the evolution of their organization and its culture. It also offers a suite of services to support Noble Production. These services include assessment services that assist clients in determining their performance relative to OSHA's Voluntary Protection Program 1 Safety criteria; culture reform services, including training and consulting services; business process management services comprising Noble Production automated process customization and business process design services; and cause analysis services, including cause analysis training and event investigations for investigating and determining the cause of conditions and incidents. In addition, the company provides consulting services in various areas, including business process management, program design and implementation, process design, procedure development and implementation, business system planning and implementation, corrective action programs, cause analysis, process safety management, and culture change management. Further, it offers training courses in various aspects of position competency, including technical training, performance training, supervision and leadership training, and other skill and knowledge based training. The company was founded in 1996 and is based in Vancouver, Washington.

Full MTPR Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MTPR vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MTPR vs SCHDMTPR vs JEPIMTPR vs OMTPR vs KOMTPR vs MAINMTPR vs JNJMTPR vs ABBVMTPR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.